Oncology Forecasting Session 1: Considerations for Design, Modeling and Alignment

Description

Oncology has become one of the top therapeutic areas for the pharmaceutical and biotechnology industries and global spending is expected to approach $200 billion within the next 3 years. The industry must contend with a variety of elements that are increasingly complex including rapid changes in treatment standards and pathways driven in part by assimilation of new technologies and biomarkers. Forecasting in this complex environment can be fraught with many pitfalls and choosing the proper approach is driven by a number of considerations related to your product, your oncology portfolio and your organization.

In this webinar, we will demonstrate considerations for developing forecasts for oncology therapeutics. Attendees will learn from real-world examples how to utilize best practices for forecast development and discuss the options for securing data to support the alternative approaches. Additionally, we will discuss elements that can have the greatest impact on forecasts and offer guidance on how to secure internal alignment on these forecasts.

Presenters:

• Bernie Manente, Foster Rosenblatt